Women with high levels of anti-Müllerian hormone more likely to develop breast cancer
Having high levels of anti-Müllerian hormone – a hormone that indicates the size of a woman’s ovarian reserve – before the menopause is associated with an increased risk of breast cancer, new research suggests.